Publications
2012
The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors.
Papac-Milicevic N,
Breuss JM,
Zaujec J,
Ryban L,
Plyushch T,
Wagner GA,
Fenzl S,
Dremsek P,
Cabaravic M,
Steiner M,
Glass CK,
Binder CJ,
Uhrin P,
Binder BR.
Circulation Research. 2012 Apr 13;110(8):e50-63.
2012
Abrogated transforming growth factor beta receptor II (TGF_RII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis.
Lievens D,
Habets KL,
Robertson AK,
Laouar Y,
Winkels H,
Rademakers T,
Beckers L,
Wijnands E,
Boon L,
Mosaheb M,
Ait-Oufella H,
Mallat Z,
Flavell RA,
Rudling M,
Binder CJ,
Gerdes N,
Biessen EA,
Weber C,
Daemen MJ,
Kuiper J,
Lutgens E.
Eur Heart J. 2012 May 21.
2012
Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL.
Elsoe S,
Ahnstrom J,
Christoffersen C,
Hoofnagle AN,
Plomgaard P,
Heinecke JW,
Binder CJ,
Bjorkbacka H,
Dahlback B,
Nielsen LB.
Atherosclerosis 221:91-97.
2012
Auto-Antigenic Protein-DNA Complexes Stimulate Plasmacytoid Dendritic Cells to Promote Atherosclerosis.
Doring Y,
Manthey H,
Drechsler M,
Lievens D,
Megens R,
Soehnlein O,
Busch M,
Manca M,
Koenen RR,
Pelisek J,
Daemen MJ,
Lutgens E,
Zenke M,
Binder CJ,
Weber C,
Zernecke A.
Circulation 2012 Apr 3;125(13):1673-83.
2012
Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells.
Bieghs V,
Verheyen F,
van Gorp PJ,
Hendrikx T,
Wouters K,
Lütjohann D,
Gijbels MJ,
Febbraio M,
Binder CJ,
Hofker MH,
Shiri-Sverdlov R.
PLoS One. 2012;7(3):e34378. Epub 2012 Mar 28.
2012
LDL Receptor Knock-Out Mice Are a Physiological Model Particularly Vulnerable to Study the Onset of Inflammation in Non-Alcoholic Fatty Liver Disease.
Bieghs V,
Van Gorp PJ,
Wouters K,
Hendrikx T,
Gijbels MJ,
van Bilsen M,
Bakker J,
Binder CJ,
Lutjohann D,
Staels B,
Hofker MH,
Shiri-Sverdlov R.
PLoS One 7:e30668.
2012
Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice.
Bieghs V,
van Gorp PJ,
Walenbergh SM,
Gijbels MJ,
Verheyen F,
Buurman WA,
Briles DE,
Hofker MH,
Binder CJ,
Shiri-Sverdlov R.
Hepatology. 2012 Sep;56(3):894-903. doi: 10.1002/hep.25660. Epub 2012 Jul 6.
2012
Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease.
Amir S,
Hartvigsen K,
Gonen A,
Leibundgut G,
Que X,
Jensen-Jarolim E,
Wagner O,
Tsimikas S,
Witztum JL,
Binder CJ.
J Lipid Res. 2012 Jul;53(7):1316-26. Epub 2012 Apr 16.
2012
Natural Antibodies and Atherosclerosis; pp.
Tsiantoulas D,
Binder CJ.
289-304 in Inflammation and Atherosclerosis; Springer; Edited by Georg Wick & Cecilia Grundtman.
2011
4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice.
Wool GD,
Cabana VG,
Lukens J,
Shaw PX,
Binder CJ,
Witztum JL,
Reardon CA,
Getz GS.
FASEB J. 2011 Jan;25(1):290-300.
